Even after months of punishment the average industry revenue multiple is around 8 (with some outliers sitting much much higher) and EBITDA multiples range from 15 to 70 (again with some much higher outliers). Margin for a broad range of medtech and telehealth business ranges from 13% to 70%.
So, to underpin a $35M market cap, in simplest terms we'd need around $4M of annual revenue. Using the most conservative quoted annual licence cost, that's 5,700 licences. Joondalup's run rate has them on track to sign over 3,500 this year if they can get an extension on the agreement.
So I'm not worried about multiples.
Ann: Application for quotation of securities - HMD, page-17
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.56M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.4¢ | 2.3¢ | $5.934K | 249.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1792299 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.7¢ | 289978 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| HMD (ASX) Chart |